Approximately 4% of patients with acute myeloid leukemia (AML) have neoplasms associated with rearrangements of the myelodysplasia syndrome 1 (MDS1) and ecotropic viral integration site 1 (EVI1) complex locus (MECOM). This evidence concerns the gene MECOM and acute myeloid leukemia.